Article Details
Retrieved on: 2024-09-12 17:53:51
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details GSK advancing an mRNA influenza vaccine, meeting safety and reactogenicity criteria in a Phase II trial, aligning with the biopharma focus on developing new vaccines. Relevant tags include 'Influenza vaccine' and 'gsk plc.'
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here